A Randomized Controlled Trial of Hydrocortisone Against Hyponatremia in Patients With Aneurysmal Subarachnoid Hemorrhage
Author(s) -
Yoichi Katayama,
Jo Haraoka,
Hidehiro Hirabayashi,
Tatsuro Kawamata,
Keiji Kawamoto,
Takao Kitahara,
Jun Kojima,
Toshihiko Kuroiwa,
Tatsuro Mori,
Nobuhiro Moro,
Izumi Nagata,
Akira Ogawa,
Kikuo Ohno,
Yoshikatsu Seiki,
Yoshiaki Shiokawa,
Akira Teramoto,
Teiji Tominaga,
Toshiki Yoshimine
Publication year - 2007
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.106.480038
Subject(s) - medicine , hydrocortisone , hyponatremia , natriuresis , placebo , subarachnoid hemorrhage , randomized controlled trial , anesthesia , gastroenterology , urology , blood pressure , alternative medicine , pathology
Hyponatremia is common after aneurysmal subarachnoid hemorrhage (SAH). It is caused by natriuresis, which induces osmotic diuresis and decreases blood volume, contributing to symptomatic cerebral vasospasm (SCV). Hypervolemic therapy to prevent SCV will not be efficient under this condition. We conducted a randomized controlled trial to assess the efficacy of hydrocortisone, which promotes sodium retention in the kidneys.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom